ORTOLANI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 2.883
AS - Asia 2.085
EU - Europa 1.799
AF - Africa 146
Continente sconosciuto - Info sul continente non disponibili 132
SA - Sud America 114
OC - Oceania 1
Totale 7.160
Nazione #
US - Stati Uniti d'America 2.840
VN - Vietnam 668
SG - Singapore 542
CN - Cina 464
GB - Regno Unito 421
DE - Germania 277
SE - Svezia 234
IT - Italia 230
HK - Hong Kong 142
FR - Francia 131
RU - Federazione Russa 102
UA - Ucraina 101
IN - India 97
BR - Brasile 87
IE - Irlanda 76
NL - Olanda 54
FI - Finlandia 44
EE - Estonia 41
BG - Bulgaria 39
JP - Giappone 34
SC - Seychelles 30
ZA - Sudafrica 28
NG - Nigeria 27
TG - Togo 27
CA - Canada 26
CI - Costa d'Avorio 25
JO - Giordania 23
KR - Corea 16
TH - Thailandia 15
IR - Iran 14
PH - Filippine 12
BD - Bangladesh 11
BE - Belgio 11
CH - Svizzera 9
EC - Ecuador 9
MX - Messico 9
TR - Turchia 7
EG - Egitto 6
IQ - Iraq 6
TW - Taiwan 6
SA - Arabia Saudita 5
AR - Argentina 4
PK - Pakistan 4
PL - Polonia 4
RO - Romania 4
CL - Cile 3
CO - Colombia 3
ES - Italia 3
GR - Grecia 3
JM - Giamaica 3
LT - Lituania 3
PE - Perù 3
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
LB - Libano 2
LV - Lettonia 2
MN - Mongolia 2
OM - Oman 2
PY - Paraguay 2
SI - Slovenia 2
UZ - Uzbekistan 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AT - Austria 1
AU - Australia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
HN - Honduras 1
HR - Croazia 1
ID - Indonesia 1
IS - Islanda 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
ME - Montenegro 1
MM - Myanmar 1
MQ - Martinica 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
PR - Porto Rico 1
QA - Qatar 1
UY - Uruguay 1
Totale 7.029
Città #
Singapore 371
Southend 363
Ashburn 313
Fairfield 262
Chandler 189
San Jose 154
Santa Clara 143
Hanoi 133
Hong Kong 133
Woodbridge 129
Houston 128
Ho Chi Minh City 123
Seattle 118
Wilmington 118
Ann Arbor 107
Cambridge 89
Princeton 88
Dong Ket 81
Dublin 75
Beijing 73
Boardman 60
Jacksonville 60
Council Bluffs 57
New York 48
Lauterbourg 42
Padova 40
Westminster 40
Sofia 37
Berlin 36
Helsinki 36
Bremen 33
Nanjing 33
Los Angeles 31
Tokyo 28
Turin 28
Abeokuta 27
Bologna 27
Lomé 27
Abidjan 25
Amman 23
Saint Petersburg 23
Buffalo 22
Changsha 22
Da Nang 22
Milan 22
Munich 22
Frankfurt am Main 19
Shenyang 17
São Paulo 17
Falkenstein 16
Guangzhou 16
Haiphong 16
Jinan 16
Medford 16
Dearborn 15
Hebei 15
Nanchang 15
Paris 13
San Diego 13
Redondo Beach 12
Brussels 11
Dallas 10
London 10
Shanghai 10
Washington 10
Chicago 9
Des Moines 9
Mülheim 9
Norwalk 9
Olalla 9
Thái Nguyên 9
Atlanta 8
Mahé 8
San Francisco 8
Toronto 8
Turku 8
Tân Tiến 8
Bangkok 7
Haikou 7
Hefei 7
Parma 7
Taiyuan 7
Tianjin 7
Verona 7
Ardabil 6
Bern 6
Bắc Ninh 6
Lanzhou 6
Mountain View 6
Rome 6
Taizhou 6
Yubileyny 6
Ancona 5
Biên Hòa 5
Düsseldorf 5
Jiaxing 5
Ninh Bình 5
Orem 5
Reggio Emilia 5
Shijiazhuang 5
Totale 4.567
Nome #
A randomised study comparing the antiplatelet and antinflammatory effect of clopidogrel 150mg/day versus 75mg/day in patients with ST-segment elevation acute myocardial infarction and poor responsiveness to clopidogrel: Results from the DOUBLE study. 273
Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality 259
Clinical comparison of "normal-hours" vs "off-hours" percutaneous coronary interventions for ST-elevation myocardial infarction. 225
Adherence to agents acting on the renin-angiotensin system in secondary prevention of non-fatal myocardial infarction: a self-controlled case-series study 218
Vascular complications after balloon aortic valvuloplasty in recent years: Incidence and comparison of two hemostatic devices 217
Diagnostic performance of standard electrocardiogram for prediction of infarct related artery and site of coronary occlusion in unselected STEMI patients undergoing primary percutaneous coronary intervention 214
Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network. 210
Le complicanze metaboliche post-trapianto di cuore ruolo dell'adiponectina ed associazione con la malattia coronarica del graft 208
How many patients with severe symptomatic aortic stenosis excluded for cardiac surgery are eligible for transcatheter heart valve implantation? 198
Coexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac Amyloidosis 196
Short- and long-term prognostic significance of ST-segment elevation in lead aVR in patients with non-ST-segment elevation acute coronary syndrome. 193
Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome. 190
Impact of a territorial ST-segment elevation myocardial infarction network on prognosis of patients with out-of-hospital cardiac arrest. 187
Safety and efficacy of early aggressive versus cholesterol-driven lipid-lowering strategies in heart transplantation: A pilot, randomized, intravascular ultrasound study. 186
Pre-hospital ECG in patients undergoing primary percutaneous interventions within an integrated system of care: reperfusion times and long-term survival benefits. 184
Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization 178
What is the acceptable rate of false positives for STEMI within a primary PCI network? Insights from a metropolitan system with direct ambulance-based access. 178
Effective and equivalent organ doses in patients undergoing coronary angiography and percutaneous coronary interventions 175
One-year clinical outcome in patients with acute coronary syndrome treated with concomitant use of clopidogrel and proton pump inhibitors: results from a regional cohort study 173
Peripheral arterial disease and long-term mortality following acute coronary syndromes: insights from a large registry of unselected patients 173
Usefulness of prehospital triage in patients with cardiogenic shock complicating ST-elevation myocardial infarction treated with primary percutaneous coronary intervention 173
Long-term prognostic role of cerebrovascular disease and peripheral arterial disease across the spectrum of acute coronary syndromes 171
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneos coronary intervention 169
Early vs. late IIb/IIIa agents administration in primary percutaneous interventions for ST-elevation myocardial infarction: results of a single centre registry 166
Il rallentamento del flusso di perfusione coronarica valutato con il TIMI frame count è in grado di predire la mortalità a lungo termine nei pazienti con trapianto di cuore 165
Prophylaxis vs. Pre-Emptive Strategies in Preventing Cytomegalovirus-Dependent Cardiac Allograft Vasculopathy 162
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention 162
Prophylaxis versus preemptive anti-cytomegalovirus approach for prevention of allograft vasculopathy in heart transplant recipients 162
Long-term effectiveness of early administration of IIb/IIIa agents to high-risk patients undergoing primary percutaneous interventions 161
Reproducibility of IVUS Measurements in Heart Transplant Recipients: Increased Quality of Data by Using Dedicated Software for Image Analysis 159
SHORT AND LONG-TERM PROGNOSTIC SIGNIFICANCE OF ST-SEGMENT ELEVATION IN LEAD AVR IN PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME 159
Predictors of 32P h brachytherapy failure in patients with high-risk in-stent restenosis 157
Occurrence of major bleeding during long-term follow up of unselected patients with STE vs NSTE Acute Coronary Syndromes 156
Standard ECG to predict culprit left main disease in unselected patients with non ST-segment elevation acute coronary syndrome 155
L'infezione da citomegalovirus e i parametri indicativi di insulino-resistenza influenzano in modo distinto e specifico le variazioni nella geometria coronarica nel primo anno dopo trapianto di cuore 151
Recent temporal trends for first-time hospitalization for acute myocardial infarction. Treatment patterns and clinical outcome in a large cohort study. 149
Predictors of beta-brachytherapy failure in patients with high-risk in-stent restenosis 143
Influence of C-reactive protein on the effectiveness of IIb/IIIa agents in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention 139
Persistence of high events rate following STE vs NSTE acute coronary syndrome in the contemporary era: 5-years outcome in a large real world registry 135
False Positive Coronary Angiography Activation in a Primary Coronary Angioplasty Network: Does Direct Ambulance-based Access Influence The Prevalence Rate? 131
Totale 7.160
Categoria #
all - tutte 18.583
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.583


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022747 0 46 48 89 69 42 12 47 25 75 157 137
2022/2023939 81 116 59 116 98 79 20 60 172 27 83 28
2023/2024274 19 34 19 33 25 88 9 11 5 10 10 11
2024/20251.000 54 140 75 108 191 46 46 32 3 87 21 197
2025/20261.987 187 108 128 135 221 106 202 87 506 188 53 66
2026/202779 27 52 0 0 0 0 0 0 0 0 0 0
Totale 7.160